IGC Pharma
5 hedge funds and large institutions have $535K invested in IGC Pharma in 2013 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Wells Fargo
San Francisco,
California
|
$470K |
| 2 |
2
Morgan Stanley
New York
|
$35K |
| 3 |
KCG
3
Knight Capital Group
|
$16K |
| 4 |
4
Creative Planning
Overland Park,
Kansas
|
$14K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Wells Fargo
San Francisco,
California
| $470K | 293,442 | +293,442 | New |
|
|
2
Morgan Stanley
New York
| $35K | 22,294 | +22,294 | New |
|
|
KCG
3
Knight Capital Group
| $16K | 10,449 | +10,449 | New |
|
|
4
Creative Planning
Overland Park,
Kansas
| $14K | 9,035 | +9,035 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $0 | 225 | +225 | New |
|